quizartinib
daiichi sankyo
['leusm']
#eha22 #leusm erba: most accrual ex-usa bec mido was approved in us while this study was ongoing. sig improvement in os adding quiz (31.9 v 15.1mo). survival best in those who recd quiz and allohct in cr1. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)